Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells

A Nitric Oxide-dependent Cross-talk between Class I and III Histone Deacetylases Accelerates Skin Repair

(2013) Francesco Spallotta et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Resveratrol Rescues SIRT1-Dependent Adult Stem Cell Decline and Alleviates Progeroid Features in Laminopathy-Based Progeria

(2012) Baohua Liu et al.   Cell Metabolism

Resveratrol in cancer management: where are we and where we go from here?

(2011) Mary Ndiaye et al.   Annals of the New York Academy of Sciences

Kinetic Tracking of Therapy-Induced Senescence Using the Real-Time Cell Analyzer Single Plate System

(2011) Timo Weiland et al.   ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

The controversial links among calorie restriction, SIRT1, and resveratrol

(2011) Yi Hu et al.   FREE RADICAL BIOLOGY AND MEDICINE

Population Pharmacokinetic Modeling of trans-Resveratrol and Its Glucuronide and Sulfate Conjugates After Oral and Intravenous Administration in Rats

(2011) Helena Colom et al.   PHARMACEUTICAL RESEARCH

Mammalian Sirtuins: Biological Insights and Disease Relevance

(2010) Marcia C. Haigis et al.   Annual Review of Pathology-Mechanisms of Disease

Regulation of SIRT1 in cellular functions: Role of polyphenols

(2010) Sangwoon Chung et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Resveratrol and derivatives for the prevention and treatment of cancer

(2010) Simone Fulda   DRUG DISCOVERY TODAY

SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1

(2010) Michelle Pacholec et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Role of HDAC6 in Cancer

(2010) Grace I. Aldana-Masangkay et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Resveratrol Arrests Cell Cycle and Induces Apoptosis in Human Hepatocellular Carcinoma Huh-7 Cells

(2010) Pei-Chi Liao et al.   JOURNAL OF MEDICINAL FOOD

Epigenetic targets of bioactive dietary components for cancer prevention and therapy

(2010) Syed M. Meeran et al.   Clinical Epigenetics

Histone Deacetylase Inhibition Activity and Molecular Docking of (E )-Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy

(2009) Didem Dayangaç-Erden et al.   Chemical Biology & Drug Design

Kinetic Cell-Based Morphological Screening: Prediction of Mechanism of Compound Action and Off-Target Effects

(2009) Yama A. Abassi et al.   CHEMISTRY & BIOLOGY

Histone deacetylase inhibitors: Potential in cancer therapy

(2009) P.A. Marks et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC

(2009) M. Emília Juan et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Epigenetics in cancer: Targeting chromatin modifications

(2009) L. Ellis et al.   MOLECULAR CANCER THERAPEUTICS

SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol

(2009) G Boily et al.   ONCOGENE

Alcohol in Moderation, Cardioprotection, and Neuroprotection: Epidemiological Considerations and Mechanistic Studies

(2008) Michael A. Collins et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Antiproliferative activities of resveratrol and related compounds in human hepatocyte derived HepG2 cells are associated with biochemical cell disturbance revealed by fluorescence analyses

(2008) Didier Colin et al.   BIOCHIMIE

Resveratrol addiction: To die or not to die

(2008) Mehdi Shakibaei et al.   MOLECULAR NUTRITION & FOOD RESEARCH

The chick embryo as a model for intrauterine ultrasound-guided heart intervention

(2008) S. Fechner et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Noggin blocks invasive growth of murine B16-F1 melanoma cells in the optic cup of the chick embryo

(2007) Christian Busch et al.   INTERNATIONAL JOURNAL OF CANCER